Uhmk1 aids colorectal cancer cell proliferation and chemoresistance through augmenting il-6/stat3 signaling

HIGHLIGHTS

• who: Xuedi Gao from the , (11624-1-AP, at a dilution of, :200, Proteintech, Wuhan, China) was carried out according to the commercial protocol (Outdo Biotech)The immunostaining was independently evaluated by two pathologists. The statistical analysis was performed as described in our previous publication [25]. In addition, another two TMAs (#HColA PG06, each contains , cases of colon cancer tissues) were obtained from Shanghai Outdo biotech for examining the expression correlation between , and STAT3. , antibody (#9139, Cell Signaling Technology, USA) was used at a dilution of, :, for IHC. The research was approved by the Medical Ethics Committees . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.